Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
CURIS
CURIS

Curis Lifesciences Ltd.

NSE: CURIS
SME
Sector: Healthcare
Industry: Pharmaceuticals
121.00-3.0 (-2.42%)
21 Aug, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
97.82
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
55.19
ROCE (TTM)
36.48
ROA (TTM)
16.24
Avg 3Y ROE
2840.88
Earnings 3Y CAGR
132.73
Sales 3Y CAGR
28.40
Sales 5Y CAGR
-
Debt/Equity
0.95
Consensus TP
-
Strong Buy %
-
Promoter Holding
68.03
Pledged %
0.00

Share Price

Track Curis Lifesciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 18.63 %
Low
109.8
High
125.0
1 Month returns: 9.50 %
Low
102.0
High
125.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Curis Lifesciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Curis Lifesciences Ltd. Shareholding Pattern

Quarterly breakdown of Curis Lifesciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Curis Lifesciences Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Curis Lifesciences Ltd.?
The current share price of Curis Lifesciences Ltd. is ₹ 121.00 as of 21 Aug 2026.
What is the market capitalisation of Curis Lifesciences Ltd.?
The market capitalisation of Curis Lifesciences Ltd. stands at ₹ 97.82 Cr.
What is the PE ratio of Curis Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Curis Lifesciences Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Curis Lifesciences Ltd.?
Curis Lifesciences Ltd. has a Return on Equity (ROE) of 55.19% and a Return on Capital Employed (ROCE) of 36.48% as per the latest financial reports.
What is the 52-week high and low of Curis Lifesciences Ltd.?
The 52-week high of Curis Lifesciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Curis Lifesciences Ltd.?
The dividend yield of Curis Lifesciences Ltd. is - based on the current market price.
What is the FII and DII holding in Curis Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 1.19%, Domestic Institutional Investors (DII) hold 0.06% and retail/public investors hold 21.34% of Curis Lifesciences Ltd. shares.
What sector does Curis Lifesciences Ltd. belong to?
Curis Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Curis Lifesciences Ltd.?
The beta of Curis Lifesciences Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Curis Lifesciences Ltd.?
The 14-day Relative Strength Index (RSI) of Curis Lifesciences Ltd. is 64.38, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.